From: Fungal exposure in homes of patients with sarcoidosis - an environmental exposure study
Group | Control | Sarcoidosis | ||
---|---|---|---|---|
Parameter | <1 year | no recurrence | recurrence | |
n | 30 | 55 | 25 | 27 |
Mean age years | 46,4 (2.7) | 43.2 (1.6) | 49.4 (2.6) | 47.7 (2.0) |
Females % | 50.0 | 55.6 | 61.9 | 44.8 |
DLCO% | - | 89 (2) | 87 (4) | 86 (4) |
BAL CD4+/CD8+ | - | 7.6 (0.9) | 5.6 (0.9) | 4.6 (0.8) |
sACE μKat/L | - | 0.43 (0.03) | 0.44 (0.04) | 0.38 (0.05) |
CTO nmol/h/mL | - | 632 (86) | 523 (91) | 513 (97) |
Total IgE mg/mL | - | 98 (26) | 125 (50) | 313 (197) |
Extrapulmonary manifestations | - | 25 | 8 | 12 |